Posted by Clinical Lab Products | Mar 18, 2010 | Miscellaneous |
A large study finds that a genetic test that samples the entire genome, known as chromosomal microarray analysis, has about three times the detection rate for genetic changes related to autism spectrum disorders (ASDs) than standard tests.
Read MorePosted by Clinical Lab Products | Mar 18, 2010 | Miscellaneous |
Ambry Genetics and RainDance Technologies jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation.
Read MorePosted by Clinical Lab Products | Mar 17, 2010 | Miscellaneous |
Spinal Muscular Atrophy (SMA) is one of many serious disorders for which prenatal testing is available. SMA affects approximately 1 in 10,000 live births and is the leading genetic cause of infant mortality and the second most common autosomal recessive disorder, after cystic fibrosis.
Read MorePosted by Clinical Lab Products | Feb 18, 2010 | Cardiovascular, Miscellaneous |
While many genetic markers have been identified as being associated with cardiovascular disease (CVD), it is unknown whether genetic screening improves a doctors ability to predict cardiac risk for events such as heart attack, stroke, coronary revascularization, or cardiovascular death.
Read MorePosted by Clinical Lab Products | Feb 17, 2010 | Miscellaneous |
Sequenom Inc announced the launch of the SensiGene Fetal(XY) (Fetal Sex Determination) test by Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM).
Read More